Stock listing
BSE:BIOCON Biocon Limited Share Price
Indian listing (BSE) of Biocon Limited · home listing NSE:BIOCON
Follow Biocon Limited into a list and get an email when it puts out news.
Home listing price · NSE:BIOCON
₹364.40 INR +2.45 (+0.7%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NSE:BIOCON
- Day range
- ₹360.90 – ₹365.70 INRNov 20, 2026
- Volume
- 1.48M sharesNov 20, 2026
- Market cap
- ₹596.8B INRAt the close on Nov 20, 2026 · price × 1.64B shares outstanding
- 52-week range
- ₹318.40 – ₹447.15 INRLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₹1.13B INRMedian day 2.65M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NSE:BIOCON · Home | ₹364.40 INR | +2.45 (+0.7%) | 1,476,514 | ₹362.90 | ₹365.70 | ₹360.90 | ₹361.95 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NSE:BIOCON · INR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₹364.40 | +2.45 | +0.7% | ₹362.90 | ₹365.70 | ₹360.90 | 1,476,514 | |
| ₹361.95 | +2.55 | +0.7% | ₹357.00 | ₹367.85 | ₹356.95 | 3,445,639 | |
| ₹359.40 | -2.80 | -0.8% | ₹362.20 | ₹363.15 | ₹358.40 | 1,968,820 | |
| ₹362.20 | -1.85 | -0.5% | ₹365.90 | ₹368.30 | ₹359.20 | 1,831,036 | |
| ₹364.05 | -6.90 | -1.9% | ₹369.80 | ₹369.80 | ₹363.65 | 2,065,437 | |
| ₹370.95 | +2.90 | +0.8% | ₹368.05 | ₹372.20 | ₹365.10 | 2,962,527 | |
| ₹368.05 | -0.45 | -0.1% | ₹371.00 | ₹373.65 | ₹367.30 | 2,883,367 | |
| ₹368.50 | +3.40 | +0.9% | ₹365.25 | ₹375.45 | ₹365.00 | 2,955,204 | |
| ₹365.10 | +3.10 | +0.9% | ₹360.00 | ₹365.90 | ₹357.35 | 5,123,511 | |
| ₹362.00 | +17.55 | +5.1% | ₹352.00 | ₹364.40 | ₹349.30 | 6,787,308 | |
| ₹344.45 | +1.45 | +0.4% | ₹341.85 | ₹349.00 | ₹336.95 | 8,966,739 | |
| ₹343.00 | -11.70 | -3.3% | ₹355.00 | ₹356.30 | ₹342.00 | 3,443,215 | |
| ₹354.70 | +2.90 | +0.8% | ₹354.70 | ₹358.00 | ₹351.50 | 2,174,472 | |
| ₹351.80 | -0.10 | 0.0% | ₹352.70 | ₹355.50 | ₹348.70 | 2,063,637 | |
| ₹351.90 | +1.20 | +0.3% | ₹351.50 | ₹357.30 | ₹349.40 | 3,113,378 | |
| ₹350.70 | +18.25 | +5.5% | ₹331.45 | ₹350.70 | ₹330.60 | 4,259,637 | |
| ₹332.45 | +3.65 | +1.1% | ₹329.80 | ₹334.65 | ₹328.00 | 3,040,821 | |
| ₹328.80 | +5.30 | +1.6% | ₹323.00 | ₹329.80 | ₹321.30 | 3,058,458 | |
| ₹323.50 | -6.80 | -2.1% | ₹330.30 | ₹330.90 | ₹318.40 | 3,471,319 | |
| ₹330.30 | -4.70 | -1.4% | ₹334.00 | ₹334.45 | ₹328.35 | 2,135,930 | |
| ₹335.00 | -5.00 | -1.5% | ₹342.00 | ₹344.00 | ₹330.75 | 2,452,266 | |
| ₹340.00 | -9.20 | -2.6% | ₹349.20 | ₹349.90 | ₹340.00 | 3,222,416 | |
| ₹349.20 | -2.80 | -0.8% | ₹352.60 | ₹353.00 | ₹348.00 | 1,876,294 | |
| ₹352.00 | +1.40 | +0.4% | ₹354.00 | ₹356.35 | ₹350.00 | 1,731,776 | |
| ₹350.60 | -0.40 | -0.1% | ₹353.00 | ₹353.00 | ₹347.00 | 3,375,381 | |
| ₹351.00 | +4.65 | +1.3% | ₹346.95 | ₹351.30 | ₹342.15 | 2,355,256 | |
| ₹346.35 | -3.05 | -0.9% | ₹348.10 | ₹351.80 | ₹345.10 | 2,632,161 | |
| ₹349.40 | -0.60 | -0.2% | ₹349.55 | ₹351.00 | ₹343.95 | 1,890,577 | |
| ₹350.00 | -10.00 | -2.8% | ₹360.50 | ₹361.15 | ₹347.20 | 2,135,284 | |
| ₹360.00 | -9.10 | -2.5% | ₹368.40 | ₹368.40 | ₹358.40 | 4,416,752 | |
| ₹369.10 | -0.70 | -0.2% | ₹369.70 | ₹371.00 | ₹366.60 | 4,647,884 | |
| ₹369.80 | -0.90 | -0.2% | ₹371.35 | ₹373.05 | ₹365.10 | 2,121,058 | |
| ₹370.70 | +0.40 | +0.1% | ₹370.55 | ₹374.25 | ₹363.60 | 2,525,268 | |
| ₹370.30 | -6.70 | -1.8% | ₹378.00 | ₹381.20 | ₹370.30 | 1,849,491 | |
| ₹377.00 | +2.10 | +0.6% | ₹376.05 | ₹379.95 | ₹373.25 | 2,779,766 | |
| ₹374.90 | -7.25 | -1.9% | ₹380.65 | ₹381.15 | ₹374.05 | 2,233,035 | |
| ₹382.15 | -4.85 | -1.3% | ₹387.50 | ₹388.70 | ₹380.50 | 2,694,397 | |
| ₹387.00 | -8.00 | -2.0% | ₹390.90 | ₹394.80 | ₹384.90 | 1,708,424 | |
| ₹395.00 | +5.00 | +1.3% | ₹389.00 | ₹397.20 | ₹388.60 | 2,665,586 | |
| ₹390.00 | -5.00 | -1.3% | ₹394.30 | ₹396.25 | ₹389.00 | 2,816,261 | |
| ₹395.00 | +10.00 | +2.6% | ₹388.30 | ₹396.15 | ₹387.60 | 3,037,626 | |
| ₹385.00 | +5.00 | +1.3% | ₹380.05 | ₹388.00 | ₹379.30 | 7,901,211 | |
| ₹380.00 | +5.60 | +1.5% | ₹374.00 | ₹382.00 | ₹370.50 | 3,043,285 | |
| ₹374.40 | -7.60 | -2.0% | ₹381.00 | ₹383.50 | ₹373.50 | 1,763,053 | |
| ₹382.00 | -8.65 | -2.2% | ₹391.95 | ₹392.05 | ₹381.00 | 2,543,144 | |
| ₹390.65 | -1.00 | -0.3% | ₹391.55 | ₹396.85 | ₹384.65 | 3,665,623 | |
| ₹391.65 | -3.35 | -0.8% | ₹397.00 | ₹397.95 | ₹388.45 | 4,737,510 | |
| ₹395.00 | +2.70 | +0.7% | ₹394.00 | ₹403.95 | ₹393.00 | 10,271,402 | |
| ₹392.30 | +0.90 | +0.2% | ₹392.15 | ₹399.90 | ₹390.90 | 2,791,301 | |
| ₹391.40 | -6.00 | -1.5% | ₹396.50 | ₹397.35 | ₹388.65 | 2,488,189 | |
| ₹397.40 | -4.60 | -1.1% | ₹404.00 | ₹404.90 | ₹396.20 | 3,108,555 | |
| ₹402.00 | +1.00 | +0.2% | ₹402.50 | ₹405.70 | ₹400.60 | 1,279,896 | |
| ₹401.00 | -0.05 | 0.0% | ₹400.00 | ₹402.40 | ₹397.90 | 1,433,504 | |
| ₹401.05 | -10.95 | -2.7% | ₹407.15 | ₹407.95 | ₹400.35 | 2,120,745 | |
| ₹412.00 | +0.90 | +0.2% | ₹411.10 | ₹412.20 | ₹401.65 | 3,746,419 | |
| ₹411.10 | -7.30 | -1.7% | ₹416.40 | ₹418.65 | ₹410.00 | 2,187,557 | |
| ₹418.40 | +0.90 | +0.2% | ₹415.00 | ₹421.60 | ₹415.00 | 1,713,404 | |
| ₹417.50 | +0.30 | +0.1% | ₹417.80 | ₹419.45 | ₹414.75 | 2,245,587 | |
| ₹417.20 | +7.80 | +1.9% | ₹410.90 | ₹417.20 | ₹407.00 | 3,087,232 | |
| ₹409.40 | -6.15 | -1.5% | ₹414.55 | ₹414.55 | ₹409.00 | 1,761,155 | |
| ₹415.55 | +3.05 | +0.7% | ₹412.50 | ₹416.00 | ₹411.00 | 2,225,359 | |
| ₹412.50 | -0.25 | -0.1% | ₹414.00 | ₹415.95 | ₹411.00 | 1,981,150 |
Splits
3 splits since 2008 · NSE:BIOCON · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 2-for-1 | Split | |
| 3-for-1 | Split | |
| 2-for-1 | Split |
- Ticker
- BSE:BIOCON
- Asset type
- Stock
- Exchange
- BSE
- Currency
- INR
What changed lately
Latest news release · Nov 18, 2026
Biocon Limited has informed the Exchange regarding a press release dated November 18, 2026, titled "Biocon s Pertuzumab Gets Marketing Authorization in EU, First Biosimilar Approved Under New Tailored Clinical Approach".
Latest deck · Nov 4, 2026
Q2 FY27 Earnings Presentation
Earnings · 18 slides
Latest news
Biocon Limited has informed the Exchange regarding a press release dated November 18, 2026, titled "Biocon s Pertuzumab Gets Marketing Authorization in EU, First Biosimilar Approved Under New Tailored Clinical Approach".
Nov 17, 2026
Closed ₹361.95 (+0.7%) on Nov 18, 2026
Biocon Limited has informed the Exchange regarding a press release dated November 16, 2026, titled "Biocon Gets U.S. FDA Approval for Pebrilzo (pertuzumab-qcay) Injection, a Biosimilar to Perjeta®, Expanding Its Oncology Portfolio".
Nov 15, 2026
Closed ₹362.20 (-0.5%) on Nov 16, 2026
Biocon Limited has informed the Exchange regarding a press release dated November 04, 2026, titled "Press Release on financial results for the quarter and half-year ended September 30, 2026".
Nov 4, 2026
Closed ₹344.45 (+0.4%) on Nov 4, 2026
Biocon Limited has informed the Exchange regarding a press release dated October 29, 2026, titled "Biocon Named Among Science Magazine s Best Employers in Global Biotech and Pharma for 2026".
Oct 28, 2026
Closed ₹351.90 (+0.3%) on Oct 29, 2026
Biocon's Pertuzumab Becomes First Biosimilar to Secure EMA CHMP Approval Recommendation Under New Tailored Clinical Approach
Sep 22, 2026
Closed ₹395.00 (+1.3%) on Sep 23, 2026
Biocon Limited Press Release Sep 21 2026
Sep 20, 2026
Closed ₹395.00 (+2.6%) on Sep 21, 2026
Biocon Limited Press Release Sep 08 2026
Sep 7, 2026
Closed ₹392.30 (+0.2%) on Sep 8, 2026
Biocon Announces Supplemental U.S. FDA Approval For Prefilled Autoinjector For YESINTEK
Sep 2, 2026
Closed ₹401.00 (0.0%) on Sep 2, 2026
Biocon Launches Aflibercept Biosimilar In The United States
Aug 24, 2026
Closed ₹409.40 (-1.5%) on Aug 24, 2026
Biocon Limited Press Release Aug 05 2026
Aug 5, 2026
Closed ₹436.60 (+2.7%) on Aug 6, 2026
Financings
Private placement of equity shares
Jan 15, 2026 · US$459.22M
Closed: ₹41.5B raised · ₹368.35 a share · Kotak Mahindra Capital Company Limited +3
Dealers: Kotak Mahindra Capital Company Limited (co-lead), HSBC Securities and Capital Markets (India) Private Limited (co-lead), J.P. Morgan India Private Limited (co-lead), Morgan Stanley India Company Private Limited (co-lead)
Buyers: SBI Mutual Fund; ICICI Prudential Mutual Fund; Mirae Asset Mutual Fund; Birla Mutual Fund; HDFC Life Insurance; ICICI Prudential Life Insurance; JPMorgan Asset Management
Use of proceeds: Cash consideration to Mylan (Viatris) for its Biocon Biologics stake, repaying related debt and debt for Edelweiss-held CCDs, and general corporate purposes
Private placement of equity shares
Jun 20, 2025 · US$519.56M
Closed: ₹45B raised · ₹330 a share · Kotak Mahindra Capital Company Limited +2
Dealers: Kotak Mahindra Capital Company Limited (co-lead), BofA India SecuriƟes India Limited (co-lead), Goldman Sachs (India) SecuriƟes Private Limited (co-lead)
Buyers: SBI Mutual Fund; ICICI PrudenƟal Mutual Fund; HDFC Life Insurance; Nippon India Mutual Fund; Mirae Asset Mutual Fund; Aditya Birla Mutual Fund; Franklin Templeton; SBI General Insurance; Government Pension Fund Global; Blackrock
Use of proceeds: Buy outstanding optionally convertible debentures of subsidiary Biocon Biologics from Goldman Sachs AIFs, repay borrowings and instruments, general corporate purposes
Decks
Q2 FY27 Earnings Presentation
Earnings · 18 slides · Nov 4, 2026
Q1 FY27 Earnings Presentation
Earnings · 16 slides · Aug 6, 2026
Investor Presentation (June 2026)
Investor deck · 31 slides · June 2026
Q4 FY26 Earnings Presentation
Earnings · 17 slides · May 8, 2026
Biocon Limited on 6ix
- News releases
- 44 in the last 12 months · 209 in all · newest Nov 18, 2026 · oldest 2020
- Decks
- 121 decks · latest Nov 4, 2026
Where Biocon Limited is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NSE:BIOCON · Home listing | NSE | India | INR |
| BSE:BIOCON · This page | BSE | India | INR |
Log in to ask 6ix AI your own questions about Biocon Limited.